ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.055 AUD 1.85% Market Closed
Market Cap: 111.3m AUD
Have any thoughts about
ImpediMed Ltd?
Write Note

Wall Street
Price Targets

IPD Price Targets Summary
ImpediMed Ltd

Wall Street analysts forecast IPD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IPD is 0.148 AUD with a low forecast of 0.091 AUD and a high forecast of 0.2 AUD.

Lowest
Price Target
0.091 AUD
65% Upside
Average
Price Target
0.148 AUD
169% Upside
Highest
Price Target
0.2 AUD
263% Upside
ImpediMed Ltd Competitors:
Price Targets
RBOT
Vicarious Surgical Inc
1% Downside
EW
Edwards Lifesciences Corp
9% Upside
ATRC
AtriCure Inc
26% Upside
INGN
Inogen Inc
9% Upside
301363
Mehow Innovative Ltd
48% Upside
2216
Broncus Holding Corp
137% Upside
STE
STERIS plc
20% Upside
MLSS
Milestone Scientific Inc
180% Upside

Revenue
Forecast

Revenue Estimate
ImpediMed Ltd

For the last 8 years the compound annual growth rate for ImpediMed Ltd's revenue is 7%. The projected CAGR for the next 3 years is 66%.

7%
Past Growth
66%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ImpediMed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
ImpediMed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IPD's stock price target?
Price Target
0.148 AUD

According to Wall Street analysts, the average 1-year price target for IPD is 0.148 AUD with a low forecast of 0.091 AUD and a high forecast of 0.2 AUD.

What is ImpediMed Ltd's Revenue forecast?
Projected CAGR
66%

For the last 8 years the compound annual growth rate for ImpediMed Ltd's revenue is 7%. The projected CAGR for the next 3 years is 66%.

Back to Top